Log In
BCIQ
Print this Print this
 

Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)

BCIQ
Print ChartPrint this
5 - Cancer 2 - Cancer 2 - Cancer 7 - Cancer 2 - Cancer 1 - Ophthalmic 16 - Cancer 1 - Renal 4 - Cancer 13 - Cancer 2 - Ophthalmic 9 - Cancer 1 - Cancer
Phase of DevelopmentDiscoveryPreclinicalPhase IPhase I/IIPhase IIPhase II/IIIPhase IIIRegistrationApprovedMarketed
Cancer

1

9

13

4

16

2

7

2

2

5

Ophthalmic

-

2

-

-

1

-

-

-

-

-

Renal

-

-

-

1

-

-

-

-

-

-




 Products Targeting Vascular endothelial growth factor (VEGF) receptor 2 (VEGFR-2) (KDR/Flk-1)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

26

$19,131.3M

$15,406.3M

$3,695.3M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today